INCB-39110-107: A Platform Study Exploring the Safety, Tolerability, Effect on the Tumor Microenvironment, and Efficacy of Pembrolizumab + INCB Combinations in Advanced Solid Tumors

February 18, 2019
https://clinicaltrials.gov/ct2/results?id=NCT02646748
Cancer - Colon Rectal, Cancer - Breast/ Genitourinary Prostate/ Lung, Cancer - Breast/ Gastro/ Lung/ Lymphoma/ Thyroid, Cancer - Head and Neck, Cancer - Lung, Cancer - Pancreatic, Cancer - Renal Cell, Solid Tumors
Principal Investigator: Ding Wang, MD
Cancer, Phase 1, Phase I, Colorectal, Colorectal cancer, Head and Neck Cancer, Lung Cancer, Breast Cancer, Pancreatic Cancer, Renal Cell, Solid Tumors, Endometrial Cancer, Pembrolizumab, INCB
Open